Adam Laponis's Insider Trades & SAST Disclosures
Adam Laponis's most recent trade in Twist Bioscience Corp was a trade of 918 Common Stock done at an average price of $44.2 . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adam Laponis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 21 Feb 2025 | 918 | 109,496 (0%) | 0% | 44.2 | 40,554 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 43.26 per share. | 10 Jan 2025 | 5,886 | 110,096 (0%) | 0% | 43.3 | 254,646 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 26,745 | 115,982 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 4,160 | 89,237 (0%) | 0% | 44.6 | 185,557 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 4,160 | 89,237 (0%) | 0% | 44.6 | 185,557 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 20,000 | 93,397 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.81 per share. | 09 Oct 2024 | 856 | 73,397 (0%) | 0% | 41.8 | 35,791 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.91 per share. | 09 Jul 2024 | 842 | 73,602 (0%) | 0% | 48.9 | 41,185 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.15 per share. | 09 Apr 2024 | 556 | 74,444 (0%) | 0% | 33.2 | 18,434 | Common Stock |
| Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 97,500 | 97,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 824 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 824 | 824 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.21 per share. | 15 Aug 2023 | 19 | 3,152 | - | 3.2 | 61 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 17 May 2023 | 19 | 3,171 | - | 4.7 | 89 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.38 per share. | 17 Feb 2023 | 21 | 3,190 | - | 7.4 | 155 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | 22 Nov 2022 | 4,995 | 64,222 | - | 0.5 | 2,498 | Common Stock | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | 22 Nov 2022 | 525 | 0 | - | - | Subscription Rights (right to buy) | ||
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 17 Nov 2022 | 687 | 59,227 | - | 0.5 | 357 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 09 Mar 2022 | 714 | 60,271 | - | 1.6 | 1,107 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.01 per share. | 09 Mar 2022 | 608 | 61,408 | - | 4.0 | 2,438 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.01 per share. | 09 Mar 2022 | 423 | 60,985 | - | 4.0 | 1,696 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 09 Mar 2022 | 357 | 59,914 | - | 1.1 | 407 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.54 per share. | 17 Aug 2021 | 359 | 62,016 | - | 24.5 | 8,809 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 10,000 | 133,692 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.43 per share. | 29 Jun 2021 | 10,000 | 60,568 | - | 38.4 | 384,300 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.55 per share. | 29 Jun 2021 | 10,000 | 70,568 | - | 2.6 | 25,500 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.99 per share. | 17 May 2021 | 362 | 60,568 | - | 34.0 | 12,303 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 16,500 | 60,930 | - | 0 | Common Stock | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | 20 Oct 2020 | 11,097 | 44,430 | - | - | Common Stock | ||
| Eargo Inc | Adam Laponis | Chief Financial Officer | 20 Oct 2020 | 11,097 | 0 | - | - | Series E Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges